BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18755453)

  • 21. Elevated urinary aluminium in current and past users of illicit heroin.
    Exley C; Ahmed U; Polwart A; Bloor RN
    Addict Biol; 2007 Jun; 12(2):197-9. PubMed ID: 17508993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE; Montgomery C; Murphy PN
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysfunctional connectivity patterns in chronic heroin users: an fMRI study.
    Liu J; Liang J; Qin W; Tian J; Yuan K; Bai L; Zhang Y; Wang W; Wang Y; Li Q; Zhao L; Lu L; von Deneen KM; Liu Y; Gold MS
    Neurosci Lett; 2009 Aug; 460(1):72-7. PubMed ID: 19450664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grid search: an innovative method for the estimation of the rates of lead exchange between body compartments.
    Brito JA; McNeill FE; Webber CE; Chettle DR
    J Environ Monit; 2005 Mar; 7(3):241-7. PubMed ID: 15735782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood lead levels in Egyptian children from high and low lead-polluted areas: impact on cognitive function.
    Mostafa GA; El-Shahawi HH; Mokhtar A
    Acta Neurol Scand; 2009 Jul; 120(1):30-7. PubMed ID: 19222397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraindicated medication use among patients in a memory disorders clinic.
    Barton C; Sklenicka J; Sayegh P; Yaffe K
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):147-52. PubMed ID: 18775389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance.
    Milewski I
    Neurology; 2008 Apr; 70(14):1221; author reply 1221-2. PubMed ID: 18378888
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
    Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
    Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addiction and cognitive functions.
    Spiga S; Lintas A; Diana M
    Ann N Y Acad Sci; 2008 Oct; 1139():299-306. PubMed ID: 18991875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reduction of exposure to particulate matter in classrooms by improved cleaning: extent of exposure and results of a pilot study in Bavaria].
    Twardella D; Fromme H; Dietrich S; Dietrich WC
    Gesundheitswesen; 2009 Feb; 71(2):70-6. PubMed ID: 19235652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation risk to the human conceptus from measurement of maternal tibial bone lead by L-line x-ray fluorescence.
    Kalef-Ezra JA; Slatkin DN; Rosen JF; Wielopolski L
    Health Phys; 1990 Feb; 58(2):217-8. PubMed ID: 2298579
    [No Abstract]   [Full Text] [Related]  

  • 33. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of primary amphetamine users in Sweden: a criminal justice population examined with the Addiction Severity Index.
    Hakansson A; Schlyter F; Berglund M
    Eur Addict Res; 2009; 15(1):10-8. PubMed ID: 19052458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience.
    Stokes L; Letz R; Gerr F; Kolczak M; McNeill FE; Chettle DR; Kaye WE
    Occup Environ Med; 1998 Aug; 55(8):507-16. PubMed ID: 9849536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lead toxicity, white matter lesions, and aging.
    Rowland AS; McKinstry RC
    Neurology; 2006 May; 66(10):1464-5. PubMed ID: 16717201
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in bone mineral density 10 years after marked reduction of cadmium exposure in a Chinese population.
    Chen X; Zhu G; Jin T; Akesson A; Bergdahl IA; Lei L; Weng S; Liang Y
    Environ Res; 2009 Oct; 109(7):874-9. PubMed ID: 19616207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of lead leachability from lead-glazed ceramic cooking vessels.
    Lynch R; Elledge B; Peters C
    J Environ Health; 2008 May; 70(9):36-40, 53. PubMed ID: 18517152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambience and drug choice: cocaine- and heroin-taking as a function of environmental context in humans and rats.
    Caprioli D; Celentano M; Dubla A; Lucantonio F; Nencini P; Badiani A
    Biol Psychiatry; 2009 May; 65(10):893-9. PubMed ID: 19217078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of heroin on frontal executive functions.
    Pau CW; Lee TM; Chan SF
    Arch Clin Neuropsychol; 2002 Oct; 17(7):663-70. PubMed ID: 14591849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.